scispace - formally typeset
R

Richard T. Ramsden

Researcher at Manchester Royal Infirmary

Publications -  162
Citations -  5581

Richard T. Ramsden is an academic researcher from Manchester Royal Infirmary. The author has contributed to research in topics: Cochlear implant & Neurofibromatosis. The author has an hindex of 36, co-authored 162 publications receiving 5257 citations. Previous affiliations of Richard T. Ramsden include University Hospitals Bristol NHS Foundation Trust & Central Manchester University Hospitals NHS Foundation Trust.

Papers
More filters
Journal ArticleDOI

Type 2 neurofibromatosis: the need for supraregional care?

TL;DR: A national NF2 register is proposed, with the management of cases at a few supraregional centres, for the special problems of NF2 cases who may go on to develop multiple spinal and cranial tumours making them wheelchair bound and blind as well as deaf.
Journal ArticleDOI

Anaesthesia of the tympanic membrane using iontophoresis

TL;DR: Experience is described of the use of iontophoresis of 2% lignocaine to achieve effective tympanic membrane anaesthesia for outpatient myringotomy and transtympanic electrocochleography.
Journal ArticleDOI

Probability of bilateral disease in people presenting with a unilateral vestibular schwannoma

TL;DR: The risk of patients with sporadic unilateral vestibular schwannomata developing a contralateral tumour in the absence of family history or other features of NF2 is low, but those presenting with other neurogenic tumours in addition to Vestibular Schwannoma are at high risk of harbouring an NF2 mutation in at least a proportion of their somatic cells.
Journal ArticleDOI

Cochlear implantation following temporal bone fracture.

TL;DR: Seven cases of profound hearing impairment following either unilateral or bilateral temporal bone fracture are presented who were implanted with the Nucleus 22 channel or Ineraid devices and the benefit of complimentary imaging with magnetic resonance (MR) is highlighted.
Journal ArticleDOI

Vestibular schwannoma: role of conservative management

TL;DR: The tumour growth rate correlated positively with tumour size in the sporadic tumour group, and correlated negatively with age in the neurofibromatosis type two group, which is an acceptable approach in carefully selected patients.